Literature DB >> 17046786

Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase.

Eran Perlson1, Izhak Michaelevski, Noga Kowalsman, Keren Ben-Yaakov, Maya Shaked, Rony Seger, Miriam Eisenstein, Mike Fainzilber.   

Abstract

Cleavage fragments of de novo synthesized vimentin were recently reported to interact with phosphorylated Erk1 and Erk2 MAP kinases (pErk) in injured sciatic nerve, thus linking pErk to a signaling complex retrogradely transported on importins and dynein. Here we clarify the structural basis for this interaction, which explains how pErk is protected from dephosphorylation while bound to vimentin. Pull-down and ELISA experiments revealed robust calcium-dependent binding of pErk to the second coiled-coil domain of vimentin, with observed affinities of binding increasing from 180 nM at 0.1 microM calcium to 15 nM at 10 microM calcium. In contrast there was little or no binding of non-phosphorylated Erk to vimentin under these conditions. Geometric and electrostatic complementarity docking generated a number of solutions wherein vimentin binding to pErk occludes the lip containing the phosphorylated residues in the kinase. Binding competition experiments with Erk peptides confirmed a solution in which vimentin covers the phosphorylation lip in pErk, interacting with residues above and below the lip. The same peptides inhibited pErk binding to the dynein complex in sciatic nerve axoplasm, and interfered with protection from phosphatases by vimentin. Thus, a soluble intermediate filament fragment interacts with a signaling kinase and protects it from dephosphorylation by calcium-dependent steric hindrance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046786     DOI: 10.1016/j.jmb.2006.09.056

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  81 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

Review 2.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

Review 3.  Signaling Over Distances.

Authors:  Atsushi Saito; Valeria Cavalli
Journal:  Mol Cell Proteomics       Date:  2015-08-21       Impact factor: 5.911

Review 4.  Intermediate filaments: versatile building blocks of cell structure.

Authors:  Robert D Goldman; Boris Grin; Melissa G Mendez; Edward R Kuczmarski
Journal:  Curr Opin Cell Biol       Date:  2008-01-04       Impact factor: 8.382

Review 5.  Nerve injury signaling.

Authors:  Namiko Abe; Valeria Cavalli
Journal:  Curr Opin Neurobiol       Date:  2008-06       Impact factor: 6.627

Review 6.  Neuroproteomics approaches to decipher neuronal regeneration and degeneration.

Authors:  Faneng Sun; Valeria Cavalli
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

7.  Axonal transport proteomics reveals mobilization of translation machinery to the lesion site in injured sciatic nerve.

Authors:  Izhak Michaelevski; Katalin F Medzihradszky; Aenoch Lynn; Alma L Burlingame; Mike Fainzilber
Journal:  Mol Cell Proteomics       Date:  2009-11-14       Impact factor: 5.911

8.  Cell death induced by the Jak2 inhibitor, G6, correlates with cleavage of vimentin filaments.

Authors:  Anurima Majumder; Annet Kirabo; Kanchana Karrupiah; Shigeharu Tsuda; Jennifer Caldwell-Busby; Arturo J Cardounel; György M Keseru; Peter P Sayeski
Journal:  Biochemistry       Date:  2011-08-17       Impact factor: 3.162

Review 9.  Axon-soma communication in neuronal injury.

Authors:  Ida Rishal; Mike Fainzilber
Journal:  Nat Rev Neurosci       Date:  2013-12-11       Impact factor: 34.870

10.  Localized regulation of axonal RanGTPase controls retrograde injury signaling in peripheral nerve.

Authors:  Dmitry Yudin; Shlomit Hanz; Soonmoon Yoo; Elena Iavnilovitch; Dianna Willis; Tal Gradus; Deepika Vuppalanchi; Yael Segal-Ruder; Keren Ben-Yaakov; Miki Hieda; Yoshihiro Yoneda; Jeffery L Twiss; Mike Fainzilber
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.